Cargando…
Re‐exposure to immunotherapy in metastatic colon cancer: A case report
Re‐exposure to immunotherapy in metastatic colorectal cancer may be indicated in selected patients that previously benefitted from immunotherapy with tolerable irAEs.
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223690/ https://www.ncbi.nlm.nih.gov/pubmed/34194811 http://dx.doi.org/10.1002/ccr3.4349 |
_version_ | 1783711744602931200 |
---|---|
author | Hamre, Tonje Riise Stougaard, Julie Kristine Havelund, Birgitte Mayland Jensen, Lars Henrik Hansen, Torben Frøstrup |
author_facet | Hamre, Tonje Riise Stougaard, Julie Kristine Havelund, Birgitte Mayland Jensen, Lars Henrik Hansen, Torben Frøstrup |
author_sort | Hamre, Tonje Riise |
collection | PubMed |
description | Re‐exposure to immunotherapy in metastatic colorectal cancer may be indicated in selected patients that previously benefitted from immunotherapy with tolerable irAEs. |
format | Online Article Text |
id | pubmed-8223690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82236902021-06-29 Re‐exposure to immunotherapy in metastatic colon cancer: A case report Hamre, Tonje Riise Stougaard, Julie Kristine Havelund, Birgitte Mayland Jensen, Lars Henrik Hansen, Torben Frøstrup Clin Case Rep Case Reports Re‐exposure to immunotherapy in metastatic colorectal cancer may be indicated in selected patients that previously benefitted from immunotherapy with tolerable irAEs. John Wiley and Sons Inc. 2021-06-24 /pmc/articles/PMC8223690/ /pubmed/34194811 http://dx.doi.org/10.1002/ccr3.4349 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Hamre, Tonje Riise Stougaard, Julie Kristine Havelund, Birgitte Mayland Jensen, Lars Henrik Hansen, Torben Frøstrup Re‐exposure to immunotherapy in metastatic colon cancer: A case report |
title | Re‐exposure to immunotherapy in metastatic colon cancer: A case report |
title_full | Re‐exposure to immunotherapy in metastatic colon cancer: A case report |
title_fullStr | Re‐exposure to immunotherapy in metastatic colon cancer: A case report |
title_full_unstemmed | Re‐exposure to immunotherapy in metastatic colon cancer: A case report |
title_short | Re‐exposure to immunotherapy in metastatic colon cancer: A case report |
title_sort | re‐exposure to immunotherapy in metastatic colon cancer: a case report |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223690/ https://www.ncbi.nlm.nih.gov/pubmed/34194811 http://dx.doi.org/10.1002/ccr3.4349 |
work_keys_str_mv | AT hamretonjeriise reexposuretoimmunotherapyinmetastaticcoloncanceracasereport AT stougaardjuliekristine reexposuretoimmunotherapyinmetastaticcoloncanceracasereport AT havelundbirgittemayland reexposuretoimmunotherapyinmetastaticcoloncanceracasereport AT jensenlarshenrik reexposuretoimmunotherapyinmetastaticcoloncanceracasereport AT hansentorbenfrøstrup reexposuretoimmunotherapyinmetastaticcoloncanceracasereport |